These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 925942)

  • 21. Improved oral absorption of L-365,260, a poorly soluble drug.
    Lin JH; Storey DE; Chen IW; Xu X
    Biopharm Drug Dispos; 1996 Jan; 17(1):1-15. PubMed ID: 8991487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.
    Bergrem H; Grøttum P; Rugstad HE
    Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. I. PSL pharmacokinetics during daily PSL treatment].
    Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):697-712. PubMed ID: 3758429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorothiazide absorption from solution and tablet dosage forms in dogs.
    Ebling WF; Murro AF; Voelker FJ; Resetarits DE; Bates TR
    J Pharm Sci; 1981 Feb; 70(2):224-6. PubMed ID: 7205233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of three formulations of diphenylhydantoin in the dog.
    Overduin LM; van Gogh H; Mol JA; van Nes JJ
    Res Vet Sci; 1989 Mar; 46(2):271-3. PubMed ID: 2704892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs.
    Baxter JG; Brass C; Schentag JJ; Slaughter RL
    J Pharm Sci; 1986 May; 75(5):443-7. PubMed ID: 3735080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of route of administration on the pharmacokinetics of methylprednisolone.
    Antal EJ; Wright CE; Gillespie WR; Albert KS
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):561-76. PubMed ID: 6678310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.
    Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose.
    McAllister WA; Winfield CR; Collins JV
    Eur J Clin Pharmacol; 1981; 20(2):141-5. PubMed ID: 7262175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of cimetidine in dogs after oral administration of cimetidine tablets.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2009 Jun; 32(3):213-8. PubMed ID: 19646084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.
    Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):453-67. PubMed ID: 3806371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent.
    Aungst BJ; Nguyen NH; Taylor NJ; Bindra DS
    J Pharm Sci; 2002 Jun; 91(6):1390-5. PubMed ID: 12115838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational study on the palatability and tolerability of oral prednisolone and oral dexamethasone in children in Saudi Arabia and the UK.
    Aljebab F; Alanazi M; Choonara I; Conroy S
    Arch Dis Child; 2018 Jan; 103(1):83-88. PubMed ID: 28735259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.